FI830378L - PYRAZOLOXAZINER, -TIAZINER, -KINOLINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNINGLAEKEMEDEL - Google Patents

PYRAZOLOXAZINER, -TIAZINER, -KINOLINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNINGLAEKEMEDEL

Info

Publication number
FI830378L
FI830378L FI830378A FI830378A FI830378L FI 830378 L FI830378 L FI 830378L FI 830378 A FI830378 A FI 830378A FI 830378 A FI830378 A FI 830378A FI 830378 L FI830378 L FI 830378L
Authority
FI
Finland
Prior art keywords
deras
tiaziner
pyrazoloxaziner
kinoliner
anvaendninglaekemedel
Prior art date
Application number
FI830378A
Other languages
Finnish (fi)
Other versions
FI830378A0 (en
Inventor
Rudolf Sundermann
Harald Horstmann
Siegfried Raddatz
Mithat Mardin
Wolf-Dieter Busse
Friedrich Hoffmeister
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI830378A0 publication Critical patent/FI830378A0/en
Publication of FI830378L publication Critical patent/FI830378L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI830378A 1982-02-06 1983-02-03 PYRAZOLOXAZINER, -TIAZINER, -KINOLINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNINGLAEKEMEDEL FI830378L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823204126 DE3204126A1 (en) 1982-02-06 1982-02-06 PYRAZOLOXAZINE, -THIAZINE, -CHINOLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT

Publications (2)

Publication Number Publication Date
FI830378A0 FI830378A0 (en) 1983-02-03
FI830378L true FI830378L (en) 1983-08-07

Family

ID=6154989

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830378A FI830378L (en) 1982-02-06 1983-02-03 PYRAZOLOXAZINER, -TIAZINER, -KINOLINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNINGLAEKEMEDEL

Country Status (16)

Country Link
US (1) US4552874A (en)
EP (1) EP0085881A3 (en)
JP (1) JPS58146583A (en)
KR (1) KR840003641A (en)
AU (1) AU1112583A (en)
DE (1) DE3204126A1 (en)
DK (1) DK49283A (en)
ES (1) ES519559A0 (en)
FI (1) FI830378L (en)
GR (1) GR77960B (en)
HU (1) HU190063B (en)
IE (1) IE830227L (en)
IL (1) IL67826A0 (en)
NO (1) NO830236L (en)
PT (1) PT76147A (en)
ZA (1) ZA83743B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO834401L (en) * 1982-12-14 1984-06-15 Troponwerke Gmbh & Co Kg PYRAZOLO (4.3-B) (1.4) OXASINES, THE PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE
US4749699A (en) * 1983-10-31 1988-06-07 Merck Frosst Canada, Inc. 5-lipoxygenease inhibitors
US4634766A (en) * 1983-10-31 1987-01-06 Merck Frosst Canada, Inc. 1,4-diaza-phenothiazines
ES537162A0 (en) * 1983-10-31 1985-12-01 Merck Frosst Canada Inc A PHARMACEUTICAL COMPOSITION
US5756747A (en) * 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US5037986A (en) * 1989-03-23 1991-08-06 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5116837A (en) * 1990-12-21 1992-05-26 Ortho Pharmaceutical Corporation 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4122035A1 (en) * 1991-07-03 1993-01-07 Henkel Kgaa THE USE OF 1,9-DIHYDRO-PYRAZOLO (4,3-B) (1,4) -BENZOXAZINES AS COUPLERS FOR OXIDATION AGENTS
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
EP0913395A1 (en) * 1995-12-08 1999-05-06 Ube Industries, Ltd. N-phenylcarbamate compounds, process for producing the same, and agricultural or horticultural bactericides
MXPA06001669A (en) 2003-08-12 2006-04-28 3M Innovative Properties Co Oxime substituted imidazo-containing compounds.
US7897597B2 (en) 2003-08-27 2011-03-01 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
EP1701955A1 (en) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
EP1730143A2 (en) 2004-03-24 2006-12-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
JP5313502B2 (en) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー Substituted chiral condensed [1,2] imidazo [4,5-c] cyclic compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2008530113A (en) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド Oxime and hydroxyramine substituted imidazo [4,5-c] ring compounds and methods
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
ES2483728T3 (en) * 2007-06-08 2014-08-07 Dart Neuroscience (Cayman) Ltd Therapeutic derivatives of pyrazolonaphathyridine
EP2164328B8 (en) * 2007-06-08 2013-09-11 Dart Neuroscience (Cayman) Ltd Therapeutic pyrazoloquinoline urea derivatives
JP2010529143A (en) * 2007-06-08 2010-08-26 ヘリコン・セラピューティクス・インコーポレーテッド Therapeutic pyrazoloquinoline derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4891096A (en) * 1972-03-08 1973-11-27
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
ES8402591A1 (en) 1984-02-01
JPS58146583A (en) 1983-09-01
FI830378A0 (en) 1983-02-03
HU190063B (en) 1986-08-28
DK49283A (en) 1983-08-07
ZA83743B (en) 1983-11-30
GR77960B (en) 1984-09-25
ES519559A0 (en) 1984-02-01
EP0085881A2 (en) 1983-08-17
PT76147A (en) 1983-02-01
KR840003641A (en) 1984-09-15
US4552874A (en) 1985-11-12
IL67826A0 (en) 1983-06-15
NO830236L (en) 1983-08-08
DK49283D0 (en) 1983-02-04
IE830227L (en) 1983-08-06
EP0085881A3 (en) 1984-03-07
AU1112583A (en) 1983-08-11
DE3204126A1 (en) 1983-08-11

Similar Documents

Publication Publication Date Title
FI830752L (en) KARBOXIALKYLDIPEPTIDER, FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH PHARMACEUTISKA BLANDNINGAR INNEHAOLLANDE DESSA
FI831591A0 (en) AZOLYLMETYLOXIRANER, DERAS FRAMSTAELLNINGSFOERFARANDE OCH DESSA INNEHAOLLANDE FUNGICIDER
FI830378A0 (en) PYRAZOLOXAZINER, -TIAZINER, -KINOLINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING LAEKEMEDEL
FI842601A0 (en) UTDELNINGSANORDNING OCH UPPTECKNINGSAPPARAT.
FI834430A (en) HAORFAERGNINGSFOERFARANDE OCH FAERGNINGSKOMPOSITIONSFOERPACKNING.
FI834888A0 (en) GONADOLIBERINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH PHARMACEUTISKA OCH VETERINAERMEDICINBLANDNINGAR FRAMSTAELLDA DAERAV
FI833398A0 (en) TERMITICIDALA ATRAKTANTFOERENINGAR, KOMPOSITION OCH FOERFARANDE FOER DERAS ANVAENDNING
FI834452A (en) AROMATISKA OLIGOMERER OCH HARTSER.
FI824126L (en) FOERFARANDE I LAONGHAOLBERGBORRNING OCH BORRSTAONGSYSTEM.
FI833857A (en) JAEMN OCH MED ROTERANDE SKIVA FOERSEDD TRYCKSIL FOER EN MEDELKONSISTENS.
FI830457L (en) LAOSANORDNING, SPECIELLT FOER LAEMMAR TILL LASTFLAK OCH DYLIKT
FI833390A (en) UTMATNINGSANORDNING MED BORTSVEPNINGSOEPPNINGAR OCH UTMATNINGSFOERFARANDE.
FI842376A0 (en) MONOSKOPISK OCH STEREOSKOPISK TELEVISIONSAPPARAT.
FI831790A0 (en) PIPERAZINDERIVAT, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE FARMACEUTISKA FOERENINGAR
FI830297L (en) BENZOTIENNYLALLYLAMINER, FOERFARANDE FOER DERAS PRODUCERING OCH DERAS ANVAENDNING SAOSOM LAEKEMEDEL
FI831367A0 (en) PLEUROMUTILLINDERIVAT, DERAS FRAMSTAELLNINGSFOERFARANDE OCH PHARMACEUTISKA ANVAENDNING
FI833292A (en) PIPERIDINDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI832789A0 (en) MJOELDRYGEALKALOIDER, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI833337A0 (en) HETEROCYCLISKA FOERENINGAR, DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE KOMPOSITIONER OCH FOERFARANDEKONTROLLERING AV OOENSKAD TILLVAEXT AV VAEXTER
FI833102A0 (en) SUBSTITUTE 1-PYRIDYLOXI-3-INDOLYLALKYL-AMINO-2-PROPANOLER, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI830206L (en) ROTERANDE, GAENGFOERSEDD BORRANDE OCH GAENGBILDANDE SKRUV
FI830992L (en) 7- -AMINOACYL-3-CHLORKEPHALOSPORINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOLAEKEMEDEL
FI821506A0 (en) SAEKERHETSKOPPLING FOER BAOTAR, MOTORSLAEDAR OCH LIKNANDE
FI823970A0 (en) SLAEPTAETNINGSMONTERING FOER FOENSTER OCH MOTSVARANDE OEPPNINGSBARA BYGGNADSDELAR, BAOGE OCH TAETNINMONTERING
FI824193L (en) FOERFARANDE OCH ANORDNING FOER TORVPRODUKTION.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT